ELIZABETH ASIN VENEREO: Open Payments
NPI 1447001383 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,869 in 58 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $304 · 2025 $1,869
Food & beverage: $1,859Education: $10
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 11 | $594 |
| Janssen Biotech, Inc. | 12 | $401 |
| Lilly USA, LLC | 5 | $189 |
| Ardelyx, Inc. | 5 | $117 |
| ABBVIE INC. | 5 | $112 |
| GENZYME CORPORATION | 4 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $96 |
| Aimmune Therapeutics, Inc. | 3 | $84 |
| Ipsen Biopharmaceuticals, Inc | 2 | $49 |
| VIVUS LLC | 2 | $34 |
Products named: REZDIFFRA, TREMFYA, OMVOH, IBSRELA, DUPIXENT, ZENPEP, RINVOQ, IQIRVO.
Industry payments across FL — which companies pay providers there.
